Mental Health

Mental Health

At Boehringer Ingelheim, we aspire to provide mental health treatment approaches that places an individual’s specific needs at the center. Our efforts go beyond pharmacologic interventions because we recognize that the needs of people living with mental health conditions are complex and highly individualized. We believe the future of care for people with mental illnesses will often involve a combination of treatment modalities that could include pharmacotherapies, behavioral therapies, psychosocial interventions, community support, and prescription digital therapeutics, to achieve more integrated and tailored solutions that enable better outcomes.

Together, we’re championing every mind for generations.

Latest Articles on Mental Health

Collage of two headshots from two men in front of a dark green background

Redefining mental health to enable people to thrive

Dr. Hugh Marston and Dr. Christoph von der Goltz discuss our long-term commitment to research with the aspiration of redefining mental healthcare.

Are you missing the bigger picture on mental health?

A woman with braided hair smiles while holding a notebook during a group discussion. Other participants sit in a blurred background, listening attentively.

Mental Health

Are you missing the bigger picture on mental health?

A revolution is needed in how we think about serious mental health conditions to ensure patients receive care tailored to their unique needs.

Mental health: a $1 trillion burden demanding policy action

Decorative image of two women laughing and spending time together

Mental Health

Mental health: a $1 trillion burden demanding policy action

Nearly one billion people around the world live with a mental health condition, yet an estimated 70% don’t have access to the help they need.

Schizophrenia is a complex mental health condition affecting approximately 24 million people worldwide and is characterized by three symptom domains: positive and negative symptoms and impaired cognition. While positive symptoms, such as hallucinations and delusions, are most widely known and treated, negative symptoms such as reduced emotion and lack of motivation and cognitive impairment that affect problem-solving, attention, and memory are currently not addressed, creating a significant unmet need for those affected.